Prosecution Insights
Last updated: November 04, 2026
Application No. 18/706,100

BIODEGRADABLE POLYMER COMPOSITIONS

Non-Final OA §102§103§112
Filed
Apr 30, 2024
Priority
Nov 01, 2021 — provisional 63/274,067 +1 more
Examiner
WOODWARD, ANA LUCRECIA
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Interfacial Consultants LLC
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
2m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
926 granted / 1258 resolved
+8.6% vs TC avg
Strong +16% interview lift
Without
With
+16.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
48 currently pending
Career history
1304
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
35.0%
-5.0% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
35.8%
-4.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1258 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 Claims 1-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 1, it is unclear how the biodegradable polymer distinguishes over the thermally stable sugars that are polymers, e.g., polysaccharides. In claim 1, the metes and bounds of the relative phrase “thermally stable” are indeterminate in scope in that no temperature conditions are recited. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-7, 9, 11, 12, 14 and 15 are rejected under 35 U.S.C. 102(a1) as being anticipated “Biobased myo-inositol as nucleator and stabilizer for poly(lactic acid)” (Tachibana). As to claim 1, Tachibana discloses a biorenewable/biodegradable composition obtained by melt mixing: poly(lactic acid) (meets Applicants’ biodegradable polymer); and myo-inositol (meets Applicants’ thermally stable sugar). While claim 1 is defined in terms of the “melt processed above their respective melt processing temperatures” product-by-process limitation“, it is not seen that the patentability of the claimed composition depends on its method of production”, In re Thorpe, 227 USPQ 964. As to claims 2 and 3, Tachibana’s composition comprises the polyester poly(lactic acid). As to claim 4, pol(lactic acid) or poly(2-hydroxypropanoic acid) is broadly classified as a polyhydroxyalkanoate. As to claims 5-7, Tachibana discloses myo-inositol has a melting point of 226°C. Thus, it would be thermally stable at the recited lower temperatures. As to claim 9, Tachibana discloses myo-inositol. As to claim 11, Tachibana discloses myo-inositol has a melting point of 226°C. As to claim 12, Tachibana’s similarly-constituted composition is used as a feedstock in the production of molded articles. As to claims 14 and 15, Tachibana’s composition is used in the production of molded articles such as films for agricultural applications. Claim Rejections - 35 USC § 102/103 Claim 1 and 5-16 are rejected under 35 U.S.C. 102(a1) and a2) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over US 2021/0301161 (Cernohous). Cernohous discloses a polymer composition comprising: a water soluble polymer inclusive of polylactic acid, polylactones, polyvinylalcohol copolymers, hydroxypropyl methylcellulose [0060] (meets Applicants’ biodegradable polymer); and a sugar inclusive of trehalose having a melting point of 203°C and inositol having a melting point of 226°C [Table 1] (meets Applicants’ thermally stable sugar) (e.g., abstract, [0006-0011], [0060-0062], [0069], Tables 1-3, examples, claims). As to claims 1, 8 and 11, Cernohous expressly sets forth [Tables 2-3] polymer compositions comprising polyvinyl alcohol-co-vinylpyrrolidinone copolymer (PVOH-co-PVP) or butanediol vinylalcohol copolymer (BVOH) (either meets Applicants’ biodegradable polymer) and trehalose or inositol (Sugars 1 and 2) (either meets Applicants’ thermally stable sugar). While claim 1 is defined in terms of the “melt processed above their respective melt processing temperatures” product-by-process limitation“, it is not seen that the patentability of the claimed composition depends on its method of production”, In re Thorpe, 227 USPQ 964. In any event, Brunner discloses [0081] the trehalose-containing compositions are obtained by mixing at temperatures up to 204°C, i.e., “at a temperature above the melting point” of the water soluble polymer and sugar” [0069] (meets Applicants’ “melt processed” product-by-process limitation). As to claims 5-7, Cernohous discloses trehalose with a melting point of 203°C. Thus, it would be thermally stable at the recited lower temperatures. As to claim 9, Cernohous expressly sets forth compositions comprising inositol (Table 3). As to claims 12 and 13, Cernohous’ compositions are used as feedstocks for making 3D printed articles [0073]/[0081-0083]. As to claims 14 and 15, Cernohous discloses the production of articles via extrusion [0081]. As to claim 16, Cernohous discloses the composition is obtained by mixing “at a temperature above the melting point” of the water soluble polymer and sugar [0069]/[0081]. Cernohous anticipates the above-rejected claims in that it is reasonably believed that the exemplified PVOH-co-PVP and BVOH polymers are biodegradable. In the alternative, it is within the purview of Cernohous’ inventive disclosure [0060], and obvious to one having ordinary skill in the art, to use other biodegradable polymers such as polylactic acid, polylactones, and hydroxypropyl methylcellulose as functional alternative water soluble polymers with the reasonable expectation of success. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 8, 10 and 13 are rejected under 35 U.S.C. 103 as being unpatentable over “Biobased myo-inositol as nucleator and stabilizer for poly(lactic acid)” (Tachibana) in view of US 2021/0301161 (Cernohous), each described hereinabove. As to claim 8, Tachibana does not expressly disclose the use of trehalose. Cernohous, however, discloses the functional interchangeability of trehalose for inositol in polymer compositions comprising polylactic acid (e.g., [0009]/[0060]). Thus, it would have been within the purview of one having ordinary skill in the art to use trehalose as a functional sugar alternative to Tachibana’s myo-inositol with the reasonable expectation of success. As to claim 10, it would have been within the purview of one having ordinary skill in the art to further include additional additives or polymers in Tachibana’s composition for their expected additive effect as taught by Cernohous [0063-0064]. As to claim 13, it would have been within the purview of one having ordinary skill in the art to use Tachibana’s composition to formulate 3D printed articles with the reasonable expectation of success as taught by Cernohous. Claims 2-4 are rejected under 35 U.S.C. 103 as being unpatentable over US 2021/0301161 (Cernohous) described hereinabove. As to claims 2-4, it would have been within the purview of Cernohous’ inventive disclosure [0060], and obvious to one having ordinary skill in the art, to use a biodegradable polyester such as polylactic acid as the water-soluble polymer for its expected additive effect. Notably, pol(lactic acid) or poly(2-hydroxypropanoic acid) is broadly chemically classified as a polyhydroxyalkanoate. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ana L Woodward whose telephone number is (571)272-1082. The examiner can normally be reached M-F 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANA L. WOODWARD/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Apr 30, 2024
Application Filed
Aug 27, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12781039
GRANULAR BODY AND USE THEREOF
5y 1m to grant Granted Nov 03, 2026
Patent 12781036
COMPOSITION INCLUDING AN ACRYLIC POLYMER, A WATER-REPELLENT POLYMER, AND AN ULTRAVIOLET LIGHT STABILIZER AND RELATED ARTICLES AND METHODS
3y 10m to grant Granted Nov 03, 2026
Patent 12781047
Polycarbonate Composition With High Comparative Tracking Index
3y 0m to grant Granted Nov 03, 2026
Patent 12774370
STABILIZED PROTEIN IONIC LIQUID APPLICATIONS
5y 0m to grant Granted Oct 27, 2026
Patent 12767760
MULTIBLOCK COPOLYMER CONTAINING POLYLACTIC ACID AND POLYAMIDE FOR TOUGHENING POLYLACTIC ACID AND METHOD FOR PREPARING THE SAME
3y 1m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
90%
With Interview (+16.2%)
2y 8m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1258 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month